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Summary 
Cyclic nucleotide-gated ion channels of retinal photo- 
receptors and olfactory neurons are differentially acti- 
vated by ligands that vary only in their purine ring 
structure. The nucleotide selectivity of the bovine rod 
cyclic nucleotide-gated channel (cGMP > clMP >> 
cAMP) was significantly altered by neutralization of 
a single aspartic acid residue in the binding domain 
(cGMP /> cAMP > clMP). Substitution by a nonpolar 
residue at this position inverted agonist selectivity 
(cAMP >> clMP t> cGMP). These effects resulted from 
an alteration in the relative ability of the agonists to 
promote the allosteric conformational change associ- 
ated with channel activation, not from a modification 
in their initial binding affinity. We propose a general 
mechanism for guanine nucleotide discrimination, in 
common with that observed in high affinity GTP- 
binding proteins, involving the formation of a pair of 
hydrogen bonds between the aspartic acid side chain 
and N1 and N2 of the guanine ring. 
Introduction 
Cyclic nucleotide-gated (CNG) channels belong to a func- 
tionally diverse family of proteins, including plant inward 
rectifier channels, cAMP- and cGMP-dependent protein 
kinases, and the catabolite gene activator protein of Es- 
cherichia coil (CAP), that all share a homologous nucleo- 
tide-binding domain. CNG channels are integral to sen- 
sory transduction in retinal photoreceptors (Yau and 
Baylor, 1989) and olfactory neurons (Lancet, 1986; Zufall 
et al., 1994), where they respond to changes in intracellu- 
lar concentrations of cGMP and cAMP, respectively. Many 
of these channels differ in their cyclic nucleotide specific- 
ity. Whereas the rod channel is highly selective for cGMP 
over cAMP, the fish olfactory CNG channel (Folf) is equally 
sensitive to cGMP and cAMP (Goutding et al., 1992). In 
addition, coexpression of subunit 2 of the rat olfactory 
channel (Rolf2) with subunit 1 (Rolf) confers increased 
sensitivity to cAMP and decreased sensitivity to cGMP 
(Bradley et al., 1994; Liman and Buck, 1994). 
The sequence of the nucleotide-binding domain of CNG 
channels is aligned with the corresponding region of CAP 
and representative cyclic nucleotide-dependent protein 
kinases in Figure 1A. The crystal structure of the cyclic 
nucleotide-binding domain of CAP complexed with cAMP 
has been previously determined (Weber and Steitz, 1987). 
Whereas the overall sequence similarity of the CNG chan- 
nels with CAP is low, most of the amino acids in the nucleo- 
tide-binding pocket of CAP are identical or conserved (see 
Figure 1A, boxes), suggesting that the tertiary structure 
may be similar. 
Altenhofen et al. (1991) showed that mutation of a con- 
served threonine (see Figure 1A, thin arrow) to alanine in 
the bovine rod and rat olfactory CNG channels decreased 
cGMP affinity, but had only small effects on apparent 
cAMP affinity. These results were interpreted to indicate 
that nucleotide specificity arises from hydrogen bonding 
between this threonine and the exocyclic 2-amine of 
cGMP, as was originally proposed for cGMP-dependent 
kinases (Weber et al., 1989). This interaction requires that 
cGMP bind the channel in the syn configuration around 
the N-glycosidic bond (Altenhofen et al., 1991; Kumar and 
Weber, 1992), rather than the anti configuration demon- 
strated for cAMP in the crystal structure of CAP (Weber 
and Steitz, 1987). However, whereas all CNG channel se- 
quences identified so far have a threonine at this position, 
not all these channels display the same agonist specificity 
for cGMP over cAMP. For example, the fish olfactory CNG 
channel (Folf) exhibits a similar response to cGMP and 
cAMP (Goulding et al., 1992), a property that has been 
localized to the putative C ~ helix region of the binding 
domain (Goulding et al., 1994). 
We used the known structure of CAP's nucleotide- 
binding domain and amino acid differences among cloned 
CNG channels as a basis for testing sites that may confer 
greater sensitivity to cAMP. Structural analysis of CAP 
has demonstrated that T127 (see Figure 1A, thick arrow) 
and $128 (from the opposite subunit) are positioned to 
form hydrogen bonds with the exocyclic amino group at 
C6 of adenine (Weber and Steitz, 1987). Furthermore, it 
has been demonstrated that this same region of CAP (the 
C ~ helix) is critical for communicating the nucleotide bind- 
ing event into a conformational change that permits se- 
quence-specific DNA binding and transcriptional regula- 
tion (Gronenborn et al., 1988; Heyduk et al., 1992; Lee et 
al., 1994). For these reasons, we have investigated the 
effects of mutations at D604 (see Figure 1A, thick arrow) 
on the allosteric transition in the bovine rod CNG channel. 
Results and Discussion 
We compared the efficiency with which different cyclic 
nucleotides activated the channel at saturating concentra- 
tions. Under these conditions, the maximal current is a 
measure of the ability of the agonist o promote the alloste- 
ric transition associated with channel opening. Figure 1 B 
shows the current evoked in expressed bovine rod CNG 
channels by saturating concentrations of cGMP, clMP, 
and cAMP. cGMP is an excellent agonist; clMP is a good 
agonist, evoking 68.4% ___ 10.4% (n = 8) of cGMP- 
mediated current; cAMP is a poor agonist, evoking only 
1.5% _+ 0.7% (n = 9) of cGMP-mediated current. Muta- 
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Figure 1. cGMP Selectivity of the Rod CNG Channel Is Determined by an Aspartic Acid Residue in the Putative Cyclic Nucleotide-Binding Domain 
(A) Amino acid sequence comparison of the cyclic nucleotide-binding domains of the catabolite gene activator protein of E. coil(CAP), representative 
CNG channels, and representative cGMP- and cAMP-dependent protein kinases. Brod, bovine rod CNG channel (Kaupp et al., 1989); Rolf, rat 
olfactory channel (Dhallan et al., 1990); Folf, fish olfactory channel (Goulding et al., 1992); Rolf2, rat olfactory channel subunit 2 (Bradley et al., 
1994; Liman and Buck, 1994); Hrod2, human rod channel subunit 2 (Chen et al., 1994); cGK IB, bovine cGMP-dependent kinase domain B (Takio 
et al., 1984b); cAK liB, bovine cAMP-dependent kinase I1~ domain B (Takio et al., 1984a). Lines above the sequence indicate secondary structure 
motifs present in the crystal structure of CAP; residues in boxes are those that line the nucleotide-binding pocket of CAP (Weber and Steitz, 1987). 
The thin arrow indicates the amino acid position previously reported to be important for discrimination between cG MP and cAMP in cyclic nucleotide- 
dependent kinases (Shabb et al., 1991) and CNG channels (Altenhofen et al., 1991). The thick arrow marks residues that align with T127 of CAP, 
which structural analysis has shown is positioned to form a hydrogen bond with the N6 amino group of the adenine ring of cAMP. 
(B) Effect on the agonist specificity of the bovine rod CNG channel produced by amino acid substitutions at position 604 (thick arrow in [A]). Current 
families are shown from inside-out patches excised from Xenopus laevis oocytes expressing wild-type and mutant channels. Current sweeps were 
elicited at saturating concentrations of cGMP (8 mM), clMP (32 raM), or cAMP (32 rnM) by voltage pulses from 0 mV to potentials between -80 
and 80 mV in 20 mV steps. Control currents in the absence of cyclic nucleotide were subtracted. 
tion of D604 to glutamine, the residue found at that position 
in Folf, produced channel subunits with altered ligand 
specificity such that Ir,,x for cGMP >i cAMP > clMP (Figure 
1B). This result can explain the findings of Goulding et al. 
(1994) that the cyclic nucleotide selectivity of Folf localized 
to the C (z helix. Substitution of D604 with methionine, the 
amino acid present at this position in Rolf2, completely 
inverted the relative agonist efficacy of the expressed 
channels, such that Ima× for cAMP > clMP >/cGMP (Figure 
1 B). This effect can account for the increase in cAMP sen- 
sitivity introduced by coexpression of Rolf2 with Rolf l  
(Bradley et al., 1994; Liman and Buck, 1994). These muta- 
tions also increased the slight inward rectification of the 
steady-state current-voltage relation. Therefore, in a CNG 
channel that is highly selective for cGMP, increased re- 
sponsiveness to cAMP can be conferred by replacement 
of D604 with amino acids found in channel subunits that 
demonstrate greater cAMP sensitivity. 
These results can be explained by the molecular mecha- 
nism outlined in Figure 2. A pair of hydrogen bonds can 
be formed between the carboxylic acid side chain of D604 
and the N1 and N2 hydrogens of cGMP (Lancelot and 
H~l~ne, 1977). This interaction between a guanine ring 
and an aspartic acid residue is identical to that shown by 
crystallographic analysis to occur in high affinity GTP- 
binding proteins such as transducin-ct (Noel et al., 1993), 
EF-Tu (Jurnak, 1985), and H-ras p21 (Pai et al., 1989). 
One less hydrogen bond is possible at this site for clMP, 
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Figure 2. Proposed Mechanism for Nucleotide Discrimination of CNG channels 
(A) cGMP, ciMP, and cAMP differ only in their structure at C6-N1-C2 (the cognate ribose and cyclic phosphate portions are not shown) and thus 
in their relative ability to hydrogen bond with residue 604. A pair of hydrogen bonds can be formed between an aspartic acid side chain and N1 
and N2 of cGMP. One hydrogen bond can be formed with N1 of clMP. A repulsive effect is predicted to occur between a negatively charged 
residue at position 604 and the nonbonding electrons in the sp 2 orbital at N1 of cAMP. 
(B) Neutralization of the aspartic acid side chain (D604Q) reduced the number and strength of the favorable interactions with cGMP and clMP, 
while eliminating the repulsive interaction with cAMP. 
accounting for its decreased effectiveness as an agonist. 
For cAMP, an unfavorable lectrostatic effect is expected 
between the negatively charged side chain and the un- 
shared pair of electrons in the sp 2 orbital at N1 of cAMP. 
Neutralization (D604Q) or replacement with a nonpolar 
amino acid (D604M) reduced the number and strength of 
the possible bonds with cGMP and clMP, while eliminating 
the repulsive forces with cAMP. Results similar to those 
obtained with D604M were observed with substitution by 
another nonpolar amino acid, D604V (data not shown). 
Thus, D604 can control agonist efficacy by determining 
the nature of interactions with the respective cyclic nucleo- 
tides. Furthermore, the greater efficacy of cAMP com- 
pared with cGMP and clMP in D604M revealed the pres- 
ence of other positive interactions with cAMP. 
To quantitate these differences in ligand discrimination, 
we used a simple model to describe the gating of CNG 
channels, in which the independent binding of two cyclic 
nucleotides is followed by a single allosteric transition from 
the liganded but closed state to the open state (Gordon 
and Zagotta, 1995; Karpen et aL, 1988): 
cNMP cNMP 
02  K - C . C< 
(1) 
In this kinetic scheme, K is the equilibrium constant for 
the initial binding of ligand, and L is the equilibrium con- 
stant for the allosteric conformational change. This model 
is a simplification of the classic allosteric model for confor- 
mational changes in proteins proposed by Monod, Wy- 
man, and Changeux (Monod et al., 1965). Although the 
model does not account for all channel behavior, it was 
sufficient o describe our data, and the qualitative conclu- 
sions stated below do not depend on the exact form of the 
kinetic scheme. Fits of this model to the dose-response 
relation for activation of wild-type and mutant CNG chan- 
nels by cGMP, clMP, and cAMP are shown in Figure 3. 
CNG channels with a conservative mutation (D604E), pre- 
serving the carboxylate side chain, resembled wild-type 
channels in both initial binding affinity and relative agonist 
efficacy (Figures 3A and 3B). As expected, neutralization 
of this residue (D604Q) or replacement with a nonpolar 
residue (D604M) dramatically altered the dose-response 
relation with respect to ligand discrimination (Figures 3C 
and 3D). Effects similar to those of D604Q were observed 
with substitution by other polar but neutral residues such 
as D604N (see Figure 4) and D604T (data not shown). 
Figure 4 shows that the energetics of the experimental 
results are compatible with the molecular interpretation 
displayed in Figure 2. For cGMP and clMP, mutation of 
D604 to a polar but neutral amino acid (D604Q or D604N) 
decreased the energy of the allosteric transition by about 
2.0 kcal/mol for cGMP and 1.6 kcal/mol for clMP. Mutation 
to a nonpolar esidue (D604M) decreased the energy by an 
additional 1.2 and 0.7 kcal/mol, respectively. Incremental 
changes observed in the free energy of the gating transi- 
tion (AG O for cGMP and clMP (Figure 4A) are consistent 
with impaired hydrogen bonding after mutation to a polar 
but neutral amino acid (D604Q or D604N) and mutation 
to a nonpolar amino acid (D604M). The lowered free en- 
ergy of the gating transition for cAMP apparent with any 
elimination of the negative charge at position 604 (approxi- 
mately -1.3 kcal/mol) is in agreement with the removal of 
an unfavorable electrostatic interaction. Note that esti- 
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Figure 3. Dose-Response Relations for Activation of Wild-Type and 
Mutant CNG Channels 
(A) Wild-type rod CNG channels; (B) D604E; (C) D604Q; (D) D604M. 
Closed squares indicate cGMP; closed triangles, clMP; open circles, 
cAMP. Currents were measured at +60 mV between 70 and 80 ms 
for small currents and within the first 5 ms for large currents, to mini- 
mize the effect of ion depletion (Zimmerman et al., 1988). The maxi- 
mum current for each patch (Po = 1) was estimated from nickel potenti- 
ation ([NF +] = 1 ~.M; Gordon and Zagotta, 1995) at saturating 
concentrations of the best agonist. A measure of agonist efficacy for 
each cyclic nucleotide was obtained from the Po at saturating concen- 
trations, using L = Po/(1 - Po). Continuous curves were fit according 
to the kinetic model described in the text (scheme 1), where K repre- 
sents the equilibrium constant for the initial cyclic nucleotide binding 
steps, and L represents the equilibrium constant for the allosteric con- 
formational change associated with channel opening (Gordon and Za- 
gotta, 1995). Parameters for each patch shown were as follows: for 
wild type, Imax = 15,678 pA, ~GMP = 19.1, L=,Mp = 0.77, ~AMP = 0.015, 
K~aMp = 4,426 M1, K~Mp = 289 M~, K~AMP = 494 M ~; for D604E, 
Im~ = 1,295 pA, LoGMP = 40.9, LduP = 0.43, L=AMP = 0.012, K~QMp = 
1,340 M 1, Kc,MP = 143 M 1, K~AMP = 184 M ~; for D604Q, I=,, = 17,902 
pA, LcGMP = 0.56, Lo,Mp = 0.14, L~AMP = 0.25, K~GMp = 1,411 M ~, 
K~,Mp = 282 M -~, I~AMP = 743 M-~; for D604M, I=~, = 13,719 pA, 
L~GMP = 0.036, L~,Mp = 0.077, L~AMP = 0.29, KOGMp = 8,455 M ~, 
K~,MP = 724 M -~, K~AMP = 1,500 M -~. 
mates of L were made at saturating nucleotide concentra- 
tions and did not depend on the specific assumptions 
made about l igand binding in scheme 1. Other amino acid 
differences in the C ~ helix (M602R, like Folf, and M602L, 
like Rolf2) did not significantly affect agonist specificity. 
Thus, D604 may play a pivotal role in coupling cyclic nucle- 
otide binding to the conformational changes associated 
with channel activation. 
In contrast, the free energy for initial binding of cyclic 
nucleotides was not substantially altered by mutations at 
position 604 (Figure 4B, AAGK). The small changes ob- 
served in the energetics of binding did not conform to the 
direction of the effects on agonist efficacy. This result sug- 
gests that interactions of the purine ring with D604 are 
not important for initial binding, but instead govern the 
allosteric conformational change leading to channel 
opening. 
Scheme 1 also provides a simple explanation for the 
change in rectification seen with D604 mutations (see Fig- 
ure 1B). The allosteric conformational change (L) exhibits 
weak voltage dependence (Karpen et al., 1988). However, 
at saturating concentrations of cGMP, the steady-state 
current-voltage relation of wild-type channels is nearly lin- 
ear, because the channels are open with a high probability 
even at negative voltages. Thus, any depolarization- 
induced increase in L can produce only a very small in- 
crease in the open probability (Po). Under conditions where 
the allosteric transition is destabilized, such as the activa- 
tion of D604 mutant channels by cGMP or clMP, a similar 
voltage-dependent change in L can produce much larger 
changes in Po, making the steady-state current-voltage 
relation rectify more strongly. 
As discussed above, T560 was previously proposed to 
control agonist specificity via hydrogen bonding to the exo- 
cyclic N2 amine of cGMP bound in the syn configuration 
(Altenhofen et al. ,  1991; Kumar and Weber, 1992). How- 
ever, compared with D604 substitutions, mutation of T560 
does not substantially alter the relative agonist efficacy of 
the channel, especial ly with respect to cG M P versus cAM P 
specificity (Figure 5A). From fits to dose-response rela- 
tions like those in Figure 3 (data not shown), we estimated 
the energetics of the T560A mutation (Figure 5B). T560A 
influenced the free energy of initial binding for cGMP 
(AAGK = +1.6 kcal/mol) more profoundly than the free 
energy of the allosteric conformational change (AAGL = 
+1.1 kcal/mol). For cAMP and clMP, T560A also made 
the free energy of initial binding less favorable, but the 
free energy of the allosteric conformational change was 
more favorable (Figure 5B). The effect of the double muta- 
tion (T560A/D604M) on agonist efficacy was not simply 
additive (Figures 5A and 5B). Whereas the D604M muta- 
tion created a channel that was largely specific for cAMP 
over cGMP, the same effect was no longer observed in 
the presence of the T560A mutation. This result suggests 
that these sites are not independent in their interaction 
with ligand. 
Since D604 mutations produced dramatic changes in 
relative agonist efficacy and implicated a direct interaction 
between D604 and N1 and N2 of guanine, we conclude 
that cyclic nucleotides may bind to the channel in the anti 
configuration (Figure 6, left) rather than the syn configura- 
tion (Figure 6, right) around the N-glycosidic bond. Based 
on the predicted structural homology with CAP, only the 
anti configuration would permit hydrogen bonding be- 
tween N1 and N2 of cGMP and amino acid side chains 
from the C ~ helix. The primary effect of the T560A muta- 
tion was on initial binding of ligand. T560 and other resi- 
dues in the putative 13 roll may be vital for initial binding 
and positioning of the cyclic nucleotide for subsequent 
dynamic interactions with D604. 
A molecular mechanism for the conformational change 
in the binding site during the opening allosteric transition 
is also suggested in Figure 6. In this model, the cyclic 
nucleotide binds to the closed channel primarily through 
interactions between the 13 roll structure and the ribose and 
phosphate of the cyclic nucleotide. The opening allosteric 
conformational change is then thought to involve move- 
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Figure 4. Substitutions at Position 604 Control Agonist Selectivity by Altering the Free Energy of the AIIostedc Gating Transition but Not of Initial 
Agonist Binding 
(A) Box plot for the free energy change of the allosteric transition (as in scheme 1). Values for L were derived as described in Figure 3 (n = 
4-13); the free energy change was calculated from AGL = -RT[In(L)]. The vertical line within each box indicates the median of the data; boxes 
show the 25th and 75th percentiles of the data; whiskers show the 5th and 95th percentiles of the data; extreme data points are also indicated. 
(B) Box plot of the change in the free energy of initial agonist binding compared with that of wild-type channels (AAGK). K was derived from fits 
of scheme 1 to the dose-response relation as in Figure 3; the free energy change was calculated from AGK = -RT[In(K)]. 
ment of the 13 roll relative to the C ~ helix (arrow), permitting 
the formation of a pair of hydrogen bonds between the 
carboxylate of D604 and N1 and N2 of the guanine ring. 
This mechanism is supported by the recent finding that 
the difference in nucleotide selectivity between the fish 
olfactory channel and the bovine rod channel is localized 
to the C c~ helix (Goulding et al., 1994). 
Striking precedent exists for this structural mechanism. 
First, mutation of the analogous residue in CAP (T127) 
similarly modified the ability of cAMP to induce transcrip- 
tional activity and altered nucleotide selectivity, but had 
little effect on the affinity for cAMP (Lee et al., 1994). Sec- 
ond, structural analysis of the GTP-binding domains of 
transducin-~ (Noel et al., 1993), EF-Tu (Ju rnak, 1985), and 
H-ras p21 (Pai et al., 1989) also predicts two crucial hydro- 
gen bonds between the guanine ring and an aspartic acid 
residue conserved among GTP-binding proteins. Indeed, 
neutralization of this analogous residue in H-ras p21 (Sigal 
et al., 1986) and EF-Tu (Hwang and Miller, 1987) similarly 
decreased nucleotide selectivity. Carboxylic acid/guanine 
ring hydrogen bonding (as in Figure 2) may be universally 
important for nucleotide discrimination among divergent 
proteins that exhibit strong guanine nucleotide selectivity. 
Experimental Procedures 
Oocyte preparation, cRNA transcription, and expression were carried 
out as described previously (Zagotta et al., 1989). Site-specific muta- 
tions were generated using oligonucleotide-directed mutagenesis via 
PCR and confirmed by sequencing, as previously described (Gordon 
and Zagotta, 1995). Patch-clamp experiments were performed with 
an Axopatch 200A amplifier in the inside-out configuration (Axon In- 
struments, Foster City, CA). Currents were low pass-filtered at 2 kHz 
(8 pole Bessel) and sampled at 10 kHz. Recordings were made at 
20°C-22°C. Data were acquired and analyzed using a Macintosh com- 
puter and Pulse software (Instrutech, Elmont, NY). Initial pipette re- 
sistances were 0.5-1 M~q. Intracellular and extracellular solutions 
contained 130 mM NaCI, 3 mM HEPES, and 0.2 mM EDTA (pH 7.2); 
500 p_M niflumic acid was included in the patch pipette to reduce 
endogenous calcium-activated chloride currents and had no effect 
on cyclic nucleotide-activated currents (data not shown). Intracellular 
solutions containing cyclic nucleotides were changed using an RSC- 
100 Rapid Solution Changer (Molecular Kinetics, Pullman, WA). 
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(A) T560A does not substantially alter the relative efficacy of cGMP versus cAMP, but does modify the effect of D604 mutations. Shown are 
representative current families at saturating concentrations of agonists, as in Figure lB. 
(B) Box plot for the free energy change of the allosteric transition (as in scheme 1). Values for L were derived as described in Figure 3 (n = 
4-9); the free energy change was calculated from AGL = -RT[In(L)]. The vertical line within each box indicates the median of the data; boxes 
show the 25th and 75th percentiles of the data; whiskers show the 5th and 95th percentiles of the data; extreme data points are also indicated, 
Figure 6. Molecular Mechanism for the Con- 
formational Change in the Binding Site during 
the AIIosteric Transition 
Model of the cyclic nucleotide-binding site of 
the CNG channel is based on analogy with CAP 
(first subunit of dimer) and results described in 
this paper. Key amino acid residues from the 
rod CNG channel were substituted into a mo- 
lecular representation of the th tee-dimensional 
structure of CAP (Weber and Steitz, 1987) 
(Maclmdad, San Francisco, CA): T560 for CAP 
$83 and D604 for CAP T127 (see Figure 1A, 
arrows), cGMP was substituted for cAMP and 
is shown in the anti (left) and syn (right) configu- 
rations around the N-glycosidic bond. Slight ro- 
tation of the torsion angles of N109 in CAP (~, 
182 ° to 166°; ~, 267.4 ° to 255o) at the junction 
between the B and C a helices was sufficient 
to permit hydrogen bonding between D604 and 
the N1 and N2 hydrogens of (anti) cGMP. Con- 
trol of agonist efficacy by D604 suggests that 
cyclic nucleotides bind to the channel in the 
anti configuration. 
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